Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study. 2015

Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, Minami-Kogushi 1-1-1, Ube City, Yamaguchi Prefecture Japan.

BACKGROUND Direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) has been widely used for patients with septic shock around the world, but the prognostic factors have not been fully understood. We conducted a retrospective analysis to determine the prognostic factors in patients with septic shock who underwent PMX-DHP. METHODS Twenty-nine patients with septic shock who underwent PMX-DHP were included in the study. The patients were divided into groups based on survival (n = 23) and non-survival (n = 6) 28 days after PMX-DHP, and the clinical data for the two groups before and after PMX-DHP were compared. RESULTS In non-survivors, the vasopressor dependency index before PMX-DHP was significantly higher (p = 0.046), and the leukocyte count before PMX-DHP was significantly lower (p = 0.024) than in survivors. Furthermore, base excess after PMX-DHP was significantly lower in non-survivors (p = 0.007) than in survivors. The optimal cutoff points of the vasopressor dependency index, leukocyte count, and base excess identified by receiver operating characteristic curves were 0.499/mmHg, 1360/μL, and -6.4 mmol/L, respectively. And the score using these three cutoffs, termed the prognostic score, was related to the prognosis of septic shock patients who underwent PMX-DHP (area under the curve = 0.946). CONCLUSIONS The prognostic score, using three parameters which are immediately and readily available in early phase after starting PMX-DHP, might be useful to predict the prognosis of these patients.

UI MeSH Term Description Entries

Related Publications

Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
April 2009, Circulation journal : official journal of the Japanese Circulation Society,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
October 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
January 2017, Journal of intensive care,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
December 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
October 2010, Journal of anesthesia,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
January 2020, Acute medicine & surgery,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
January 2004, Journal of endotoxin research,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
October 2018, Clinical and experimental nephrology,
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
October 2011, Shock (Augusta, Ga.),
Satoshi Matsukuma, and Kazuhiko Sakamoto, and Mitsuo Nishiyama, and Takao Tamesa, and Shigefumi Yoshino, and Shoichi Hazama, and Rumi Oshibuchi, and Norimasa Matsuda, and Satoshi Matsumoto, and Hiroya Wakamatsu, and Ryosuke Tsuruta, and Mishiya Matsumoto, and Masaaki Oka
September 2013, Shock (Augusta, Ga.),
Copied contents to your clipboard!